Researcher Marketers

 IMARC Group, a leading market research company, has recently releases report titled “ Pharmacovigilance and Drug Safety Software Market Report by Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software), Delivery Mode (On-premises, Cloud-based), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, and Others), and Region 2024-2032 ”, Offers a comprehensive analysis of the industry, which comprises insights on the market. How Big Is the Pharmacovigilance and Drug Safety Software Market? The global pharmacovigilance and drug safety software market size reached US$ 202.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 341.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032. Factors Affecting the Growth of the Pharmacovigilance and Drug Safety Software Industry: Regulatory Compliance and Re...

  The latest research study “ Pharmacovigilance and Drug Safety Software Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ” by IMARC Group, finds that the global pharmacovigilance and drug safety software market reached a value of  US$ 176.6 Million  in 2021. Looking forward, IMARC Group expects the market to reach a value of  US$ 265 Million  by 2027 exhibiting a  CAGR of 6.60%  during 2022-2027. Pharmacovigilance and drug safety software is used to assess, detect, understand, and prevent adverse effects related to medicines, medical devices, and pharmaceutical products. It is utilized by various healthcare companies and organizations to ensure global regulatory compliance, make faster science-based safety decisions, integrate safety and risk management, and lower the overall costs. As manual processing and classification of adverse event reports are costly and time-consuming, companies are increasingly...